ArticleCells2022

Adding Cyclooxygenase Inhibitors to Immune Checkpoint Inhibitors Did Not Improve Outcomes in Metastatic Renal Cell Carcinoma.

Yumeng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.